Diarmuid Moran

Head of Precision Medicine & Diagnostics (R&D) Astellas Pharma

Seminars

Wednesday 7th October 2026
Panel Discussion: Innovating Global Rx-Dx Trial Pathways Through Strategic & Compliant Co-Development Partnerships to Deliver Harmonized Precision Medicine Solutions
3:10 pm
  • When should biomarker evidence trigger CDx development, and how can strategies align with therapeutic goals, clinical endpoints, and regulatory requirements?
  • How can organizations build adaptable CDx strategies that support clinical development while addressing regional differences in regulation, testing infrastructure, and clinical practice?
  • What is the impact of regulations, and added considerations for executing this strategy, partnerships and co-development?
Diarmuid_Muran[1]
View all Speakers
View Event Brochure